University of Chicago’s Bristol-Myers Squibb BMY Stock Holding History

University of Chicago’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,500	Closed	-$241K	–	3
2014 Q4	$241K	Buy	+4,500	New	+$254K	6.93%	3
2014 Q1	–	Sell	-4,500	Closed	-$239K	–	3
2013 Q4	$239K	Buy	+4,500	New	+$229K	0.36%	3

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

University of Chicago's BMY Position: Q1 2015 in Review

University of Chicago sold out of Bristol-Myers Squibb (BMY) in Q1 2015, closing a stake of 4,500 shares — an estimated $241K sold.

University of Chicago first reported a position in BMY in Q4 2013 and held it in 2 quarters. The position peaked at $241K in Q4 2014. 1,450 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

University of Chicago reported no remaining Bristol-Myers Squibb position as of Q1 2015 after selling out during the quarter.
University of Chicago sold 4,500 Bristol-Myers Squibb shares in Q1 2015, an estimated $241K.
University of Chicago first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 2 quarters.
University of Chicago's Bristol-Myers Squibb position peaked at $241K in Q4 2014.
1,450 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on University of Chicago's 13F filing for Q1 2015, filed 14 May 2015.